Updated:
May 28, 2021 23:46 IST
It said that as on date, India was using three vaccines against COVID-19 in its immunisation drive
Share Article
AAA
A health worker shows Covishield and Covaxin vaccines, in Bengaluru. File
| Photo Credit:
K. Murali Kumar
It said that as on date, India was using three vaccines against COVID-19 in its immunisation drive The Central government is holding regular talks with national and international vaccine manufacturers like Pfizer, Moderna etc. to make COVID-19 vaccines available in the country, said the Health Ministry on Friday in a statement.
It said that as on date, India was using three vaccines against COVID-19 in its immunisation drive. This included two ‘made in India’ vaccines Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin, who have supplied about 7.92 crore vaccine doses in the month of May 2021.
Vinod Paul, head of India s coronavirus task force, said the analysis by the New York Times was not backed by any evidence and is based on distorted estimates.
Last week the virus-ravaged Asian nation, whose health system has been brought to the brink, recorded 4,529 deaths in one day, the biggest 24-hour toll in any country during the pandemic.
Updated:
A select list of stories to read before you start your day.
Share Article
AAA
Dark clouds hover in the sky ahead of cyclone Yaas in Kolkata on May 24, 2021.
| Photo Credit:
PTI
A select list of stories to read before you start your day.
As the storm system Yaas heads towards the north Odisha-West Bengal coast, several thousand people are set to be evacuated from the coastal districts of both States. Officials of the Regional Meteorological Centre (RMC) in Kolkata said on Monday that the very severe cyclonic storm will make landfall by Wednesday.
External Affairs Minister S. Jaishankar and his American counterpart Antony Blinken will discuss COVID-19 relief, multilateralism and the Quad during the Minister’s visit to Washington this week, according to the U.S. State Department. Mr. Jaishankar is on a visit to New York and Washington DC, from May 24 to 27.